A detailed history of Allworth Financial LP transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Allworth Financial LP holds 44 shares of PRTA stock, worth $669. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44
Previous 32 37.5%
Holding current value
$669
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$16.73 - $24.79 $200 - $297
12 Added 37.5%
44 $0
Q2 2024

Jul 23, 2024

SELL
$19.54 - $26.15 $1,074 - $1,438
-55 Reduced 63.22%
32 $0
Q1 2024

Apr 25, 2024

SELL
$24.75 - $40.66 $990 - $1,626
-40 Reduced 31.5%
87 $2,000
Q4 2023

Jan 24, 2024

BUY
$32.31 - $52.32 $3,295 - $5,336
102 Added 408.0%
127 $4,000
Q3 2023

Oct 31, 2023

BUY
$47.3 - $70.6 $94 - $141
2 Added 8.7%
25 $1,000
Q1 2023

Apr 18, 2023

SELL
$46.97 - $58.27 $2,113 - $2,622
-45 Reduced 66.18%
23 $1,000
Q4 2022

Jan 13, 2023

BUY
$52.05 - $65.0 $676 - $845
13 Added 23.64%
68 $0
Q3 2022

Oct 18, 2022

BUY
$25.16 - $60.63 $805 - $1,940
32 Added 139.13%
55 $3,000
Q3 2021

Nov 02, 2021

BUY
$48.2 - $78.89 $530 - $867
11 Added 91.67%
23 $2,000
Q1 2019

May 07, 2019

BUY
$10.32 - $14.49 $123 - $173
12 New
12 $0

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $714M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.